查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1628123

冠狀動脈支架市場機會、成長動力、產業趨勢分析與預測 2025 - 2034

Coronary Stents Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年，全球冠狀動脈支架市場估值為 75 億美元，預計 2025 年至 2034 年複合年成長率為 7.2%。人們越來越偏愛微創治療。此外，人口老化和日益嚴重的健康問題也大大促進了市場的擴張。

冠狀動脈支架是透過保持狹窄或阻塞的動脈暢通來維持血流的重要裝置，在治療冠狀動脈疾病 (CAD) 方面發揮著至關重要的作用。對這些設備的需求不斷成長源於不健康的生活方式、人口老化以及心血管疾病發病率的上升。生物可吸收支架、藥物洗脫支架 (DES) 和無聚合物支架等創新開發可透過降低動脈再狹窄和血栓相關的風險來提高治療效果。

市面上依產品分為生物可吸收血管支架（BVS）、藥物洗脫支架及裸金屬支架。藥物洗脫支架在 2024 年佔據市場主導地位，因其卓越的預防再狹窄能力而產生了可觀的收入。這些支架會釋放藥物來抑制組織生長，減少重複手術的需要並改善患者的長期治療效果。

市場範圍
開始年份 2024年
預測年份 2025-2034
起始值 75 億美元
預測值 148 億美元
複合年成長率 7.2%

從類型來看，市場包括球囊擴張式支架和自擴張式支架。 2024年球囊擴張支架佔最大市場佔有率，佔58.3%。它們在部署過程中的精確性和控制性使其對於治療複雜或狹窄的動脈病例非常有效。這些支架特別有利於解決鈣化病灶和硬化斑塊，進一步提高其採用率。

依材料分類，市場分為鈷鉻合金、不鏽鋼等。鈷鉻合金支架在2024年佔據領先地位，預計到預測期結束時將達到76億美元。這種材料具有卓越的強度和耐用性，可實現更薄、更有效的設計，從而減少動脈損傷並改善血流。

最終用途細分重點關注心臟中心、醫院和門診手術中心，其中心臟中心將在 2024 年引領市場。

2024 年，北美地區以 30 億美元的收入引領市場。強大的醫療保健系統、廣泛的先進心臟護理服務以及較高的心血管疾病發病率支撐了該地區強大的市場地位。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 冠狀動脈疾病負擔增加
      • 微創手術的需求不斷增加
      • 發展中經濟體的技術進步
      • 提高對預防性心臟護理的認知和關注
    • 產業陷阱與挑戰
      • 產品故障和召回
      • 嚴格的法規核准
      • 發展中經濟體缺乏熟練的醫療保健專業人員
  • 成長潛力分析
  • 技術景觀
  • 未來市場趨勢
  • 監管環境
  • 報銷場景
  • 差距分析
  • 定價分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按產品分類，2021 - 2034 年

  • 主要趨勢
  • 藥物洗脫支架
  • 生物可吸收血管支架（BVS）
  • 裸金屬支架

第 6 章：市場估計與預測：按類型，2021 - 2034 年

  • 主要趨勢
  • 球囊一次性支架
  • 自費式支架

第 7 章：市場估計與預測：按材料分類，2021 - 2034 年

  • 主要趨勢
  • 鈷鉻合金
  • 不銹鋼
  • 其他材料

第 8 章：市場估計與預測：按最終用途，2021 - 2034 年

  • 主要趨勢
  • 心臟中心
  • 醫院
  • 門診手術中心
  • 其他最終用戶

第 9 章：市場估計與預測：按地區分類，2021 - 2034 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 10 章：公司簡介

  • Abbott Laboratories
  • Andramed GmbH
  • B. Braun Melsungen
  • Biosensors International Group
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical
  • Elixir Medical Corporation
  • GENOSS
  • Medtronic
  • Meril Life Science
  • MicroPort Scientific Corporation
  • Sahajanand Laser Technology
  • Stryker Corporation
  • Terumo Corporation
簡介目錄
Product Code: 2966

The Global Coronary Stents Market was valued at USD 7.5 billion in 2024 and is projected to grow at a CAGR of 7.2% from 2025 to 2034. This growth is driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in stent technologies, and a growing preference for minimally invasive treatments. In addition, the aging population and rising health concerns contribute significantly to market expansion.

Coronary stents are vital devices used to maintain blood flow by keeping narrowed or blocked arteries open, playing a crucial role in managing coronary artery disease (CAD). The growing demand for these devices stems from unhealthy lifestyles, aging populations, and the rising incidence of cardiovascular conditions. Innovative developments like bioresorbable scaffolds, drug-eluting stents (DES), and polymer-free stents are enhancing treatment outcomes by reducing risks associated with artery re-narrowing and blood clots.

The market is segmented by product into bioresorbable vascular scaffolds (BVS), drug-eluting stents, and bare-metal stents. Drug-eluting stents dominated the market in 2024, generating significant revenue due to their superior ability to prevent restenosis. These stents release medication to inhibit tissue growth, reducing the need for repeat procedures and improving long-term patient outcomes.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$7.5 Billion
Forecast Value$14.8 Billion
CAGR7.2%

In terms of type, the market includes balloon-expandable and self-expandable stents. Balloon-expandable stents captured the largest market share in 2024, accounting for 58.3%. Their precision and control during deployment make them highly effective for treating complex or narrow artery cases. These stents are particularly beneficial for addressing calcified lesions and hardened plaque, further enhancing their adoption.

By material, the market is segmented into cobalt-chromium alloy, stainless steel, and others. Stents made of cobalt-chromium alloy held the leading position in 2024 and are expected to reach USD 7.6 billion by the end of the forecast period. This material offers exceptional strength and durability, allowing for thinner, more effective designs that reduce artery injuries and improve blood flow.

End-use segmentation highlights cardiac centers, hospitals, and ambulatory surgical centers, with cardiac centers leading the market in 2024. These facilities offer advanced technologies and specialized expertise, ensuring high-quality care for complex cardiac procedures.

North America led the market in 2024, with revenues of USD 3 billion. A robust healthcare system, widespread access to advanced cardiac care, and high rates of cardiovascular disease support the region's strong market position.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising burden of coronary artery disease
      • 3.2.1.2 Increasing demand for minimally invasive procedures
      • 3.2.1.3 Technological advancement in developing economies
      • 3.2.1.4 Increasing awareness and focus on preventive cardiac care
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Product failure and recall
      • 3.2.2.2 Stringent regulatory approvals
      • 3.2.2.3 Dearth of skilled healthcare professional in developing economies
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Future market trends
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Gap analysis
  • 3.9 Pricing analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Drug-eluting stent
  • 5.3 Bioresorbable vascular scaffold (BVS)
  • 5.4 Bare metal stent

Chapter 6 Market Estimates and Forecast, By Type, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Balloon expendable stent
  • 6.3 Self-expendable stent

Chapter 7 Market Estimates and Forecast, By Material, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cobalt-chromium alloy
  • 7.3 Stainless steel
  • 7.4 Other materials

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Cardiac centers
  • 8.3 Hospitals
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 Andramed GmbH
  • 10.3 B. Braun Melsungen
  • 10.4 Biosensors International Group
  • 10.5 Biotronik SE & Co. KG
  • 10.6 Boston Scientific Corporation
  • 10.7 Cook Medical
  • 10.8 Elixir Medical Corporation
  • 10.9 GENOSS
  • 10.10 Medtronic
  • 10.11 Meril Life Science
  • 10.12 MicroPort Scientific Corporation
  • 10.13 Sahajanand Laser Technology
  • 10.14 Stryker Corporation
  • 10.15 Terumo Corporation